Corcept Therapeutics
CORT
$25.06
Share price
4.94%
Change (1 day)
11.92%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.11 B
According to Corcept Therapeutics 's latest financial reports the company's total liabilities are $0.11 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | 40.72% |
| 2022-12-31 | $81.58 M | 70.15% |
| 2021-12-31 | $47.95 M | -0.92% |
| 2020-12-31 | $48.39 M | 17.66% |
| 2019-12-31 | $41.13 M | 14.85% |
| 2018-12-31 | $35.81 M | 21.11% |
| 2017-12-31 | $29.56 M | 8.02% |
| 2016-12-31 | $27.37 M | -18.05% |
| 2015-12-31 | $33.4 M | -12.14% |
| 2014-12-31 | $38.01 M | -9.61% |
| 2013-12-31 | $42.06 M | 12.49% |
| 2012-12-31 | $37.38 M | 643.91% |
| 2011-12-31 | $5.02 M | 30.21% |
| 2010-12-31 | $3.86 M | 59.57% |
| 2009-12-31 | $2.41 M | -15.66% |
| 2008-12-31 | $2.86 M | -4.72% |
| 2007-12-31 | $3.01 M | -15.02% |
| 2006-12-31 | $3.54 M | -0.59% |
| 2005-12-31 | $3.56 M | 95.34% |
| 2004-12-31 | $1.82 M | -95.78% |
| 2003-12-31 | $43.25 M | -1.1% |
| 2002-12-31 | $43.73 M | 2221.39% |
| 2001-12-31 | $1.88 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 85,939.79% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 47,436.84% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 119,411.03% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | 46,186.63% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 60,033.09% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 71,741.79% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.72 B | 528.30% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.66 B | 475.54% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 1,546.21% | 🇺🇸 USA |